Financial Daily from THE HINDU group of publications
Thursday, Jan 20, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate Results - Pharmaceuticals


Shasun Chemicals Q3 net up 60 pc

Our Bureau

Chennai , Jan. 19

SHASUN Chemicals and Drugs Ltd has reported a net profit of Rs 9.01 crore for the third quarter of the current year, compared with Rs 5.50 crore for the same period last year — a 60 per cent rise.

Revenues for the quarter was up at Rs 78.24 crore, against Rs 70.83 crore in Q3 last year.

In the nine months ended December 31, 2004, Shasun made a net profit of Rs 18.63 crore, against Rs 13.58 crore in the same period last year — an increase of 37 per cent.

Higher export sales at Rs 163 crore (Rs 130 crore) contributed to the rise in turnover, which stood at Rs 231.53 crore (Rs 199.70 crore).

Shasun's officials told Business Line that the company expects revenues from contract research and manufacturing services (CRAMS) business to double to about Rs 40 crore in the current financial year.

The company has targeted a 20 per cent growth in turnover for the full year. Its turnover in 2003-04 was Rs 277.42 crore.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
Shree Cement net zooms


PSL Q3 net rises 87 pc
Taj GVK Q3 net up 45 pc
Merck net dips 7 pc in Q4
Shasun Chemicals Q3 net up 60 pc
Reliance Energy Q3 net rises 152%
Uttam Galva Steels net rises
Indo Rama Synthetics Q3 net down 70.13 pc
TV 18 net profit up 55 pc
HMT back in black
Bajaj Auto Q3 PAT up at Rs 182.7 cr
Hughes Soft Q3 net at Rs 28 cr
Zen Tech net up
Asian Paints net up 20.7 per cent
Goodlass Nerolac Q3 net rises 67 pc to Rs 28.33 cr
Deccan Chronicle Holdings Q3 net rises 97 pc


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line